Role of interleukin-6 in paraneoplastic thrombocytosis

Molecular profiling and access to treatment for rare cancers in Europe.

Nature communications·2026

Artificial intelligence in medicine: a scoping review of the risk of deskilling and loss of expertise among physicians.

ESMO real world data and digital oncology·2026

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

medRxiv : the preprint server for health sciences·2026

Radiation-associated angiosarcoma of the breast: consider chemotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025

COREGO: drug-drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials.

ESMO open·2025

Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Blood·2026

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

Blood·2026

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Blood·2026

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Blood·2026

Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

Blood·2026

CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

Blood·2026

IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway.

American journal of cancer research·2026

Mechanism and intervention strategy of thymus atrophy in cancer immunotherapy.

American journal of cancer research·2026

Suspected recurrent sarcoma resembling feline injection-site sarcoma with spinal cord invasion in a cat.

JFMS open reports·2026

Disulfidptosis as an immunometabolic rheostat in gastrointestinal cancers: tuning the balance between T Cell exhaustion and immunogenic cell death.

Frontiers in cell and developmental biology·2026

Immune checkpoint inhibitors in thymic epithelial tumors: current evidence, immune-related toxicity, and perioperative considerations-a narrative review.

Journal of thoracic disease·2026

Molecularly guided management of pediatric endobronchial inflammatory myofibroblastic tumor: a report of two cases on surgical and targeted intervention.

Translational pediatrics·2026

Related Experiment Videos

Role of interleukin-6 in paraneoplastic thrombocytosis

Related Concept Videos

Molecular profiling and access to treatment for rare cancers in Europe.

Artificial intelligence in medicine: a scoping review of the risk of deskilling and loss of expertise among physicians.

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Radiation-associated angiosarcoma of the breast: consider chemotherapy.

COREGO: drug-drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials.

Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial.

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway.

Mechanism and intervention strategy of thymus atrophy in cancer immunotherapy.

Suspected recurrent sarcoma resembling feline injection-site sarcoma with spinal cord invasion in a cat.

Disulfidptosis as an immunometabolic rheostat in gastrointestinal cancers: tuning the balance between T Cell exhaustion and immunogenic cell death.

Immune checkpoint inhibitors in thymic epithelial tumors: current evidence, immune-related toxicity, and perioperative considerations-a narrative review.

Molecularly guided management of pediatric endobronchial inflammatory myofibroblastic tumor: a report of two cases on surgical and targeted intervention.

Related Experiment Videos

Role of interleukin-6 in paraneoplastic thrombocytosis

Related Concept Videos

Related Articles